Insufficient scRNA-seq data for expression of CHRM4 at single-cell level.
Insufficient scRNA-seq data for expression of CHRM4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 69% | 311.70 | 1815 / 2642 | 86% | 5.77 | 609 / 705 |
spleen | 96% | 659.08 | 231 / 241 | 0% | 0 | 0 / 0 |
intestine | 81% | 126.44 | 779 / 966 | 12% | 0.41 | 65 / 527 |
skin | 62% | 91.20 | 1127 / 1809 | 13% | 0.37 | 60 / 472 |
adrenal gland | 11% | 6.31 | 28 / 258 | 46% | 4.19 | 106 / 230 |
stomach | 31% | 23.58 | 111 / 359 | 20% | 0.97 | 58 / 286 |
esophagus | 29% | 17.99 | 426 / 1445 | 15% | 0.40 | 27 / 183 |
breast | 9% | 3.97 | 42 / 459 | 21% | 0.86 | 231 / 1118 |
lung | 11% | 4.76 | 61 / 578 | 18% | 0.57 | 203 / 1155 |
pancreas | 1% | 0.30 | 3 / 328 | 26% | 1.17 | 46 / 178 |
ovary | 2% | 0.81 | 4 / 180 | 20% | 0.65 | 88 / 430 |
uterus | 3% | 1.13 | 5 / 170 | 17% | 0.53 | 77 / 459 |
thymus | 1% | 0.30 | 5 / 653 | 14% | 7.86 | 87 / 605 |
bladder | 5% | 1.62 | 1 / 21 | 9% | 0.34 | 45 / 504 |
eye | 0% | 0 | 0 / 0 | 9% | 0.20 | 7 / 80 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.53 | 3 / 45 |
adipose | 7% | 2.72 | 80 / 1204 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 6% | 0.28 | 52 / 901 |
peripheral blood | 6% | 3.91 | 53 / 929 | 0% | 0 | 0 / 0 |
prostate | 3% | 1.44 | 8 / 245 | 2% | 0.03 | 10 / 502 |
blood vessel | 4% | 1.40 | 49 / 1335 | 0% | 0 | 0 / 0 |
heart | 3% | 1.58 | 28 / 861 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 3% | 0.11 | 11 / 406 |
muscle | 0% | 0.13 | 3 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0007197 | Biological process | adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0007213 | Biological process | G protein-coupled acetylcholine receptor signaling pathway |
GO_0098664 | Biological process | G protein-coupled serotonin receptor signaling pathway |
GO_0040012 | Biological process | regulation of locomotion |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0007187 | Biological process | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0030425 | Cellular component | dendrite |
GO_0005886 | Cellular component | plasma membrane |
GO_0045202 | Cellular component | synapse |
GO_0004993 | Molecular function | G protein-coupled serotonin receptor activity |
GO_0016907 | Molecular function | G protein-coupled acetylcholine receptor activity |
Gene name | CHRM4 |
Protein name | Muscarinic acetylcholine receptor M4 Muscarinic acetylcholine receptor |
Synonyms | |
Description | FUNCTION: The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is inhibition of adenylate cyclase. FUNCTION: The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. . |
Accessions | Q96RG8 P08173 ENST00000433765.3 ENST00000682254.1 |